-
December 1, 2025
APDA President & CEO Leslie A. Chambers talks about her reflections on past WPC events, the benefits and importance of WPC, APDA’s organizational priorities and impactful resources, and so much more.
-
November 18, 2025
APDA’s President and CEO, Leslie A. Chambers, talks about PD awareness, research, the many ways APDA can help, and so much more in a discussion with George Ackerman.
-
September 10, 2025
Article about the exciting research projects APDA is funding for the 2025-2026 year and a significant increase in research funding.
-
August 6, 2025
Dr. Rebecca Gilbert was a special guest on The Spark. During the conversation she spoke about the basics of Parkinson’s disease, the early signs and symptoms to look out for, the impact of PD on families, and more.
-
June 10, 2025
A recent study in the Journal of the American Medical Association has caused a stir, showing that living near golf courses is associated with an increased risk of Parkinson’s disease. Dr. Rebecca Gilbert comments on the implications of this study.
-
May 22, 2025
Dr. Rebecca Gilbert, APDA’s Chief Mission Officer, talks about the early signs of Parkinson’s disease, the non-motor symptoms of PD people should be aware of, and so much more, in a discussion with George Ackerman.
-
May 19, 2025
A growing body of research finds that regular physical activity — the kind that gets the body moving and the heart pumping — can significantly reduce the severity of PD symptoms and how fast they progress. Dr. Rebecca Gilbert comments on the importance of exercise and the benefits of movements that challenge your brain to think and learn, like dance.
-
April 11, 2025
A potential new blood test shows promise for early diagnosis. Dr. Rebecca Gilbert comments on the benefits of a test like this for the PD community.
-
April 2, 2025
This round-up of PD Awareness Month activities highlights APDA’s “Did You Know” campaign and April events and activities across the country.
-
March 21, 2025
Dr. Rebecca Gilbert comments on the newly-available adaptive deep brain stimulation device, which is being deployed for the first time in the United States, indicating "it stands to reason that adaptive DBS would result in better symptom management for each individual, and I am eager to see how that unfolds. This has the potential to be a game-changer.”








